MESO QuickPlex SQ 120MM Electrochemiluminescence Multiplexing Instrument
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH), specifically the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK), intends to award a Firm-Fixed-Price purchase order to Meso Scale Diagnostics LLC for a MESO QuickPlex SQ 120MM Electrochemiluminescence Multiplexing Instrument. This instrument is crucial for multi-biomarker analyses on clinical and research biospecimens to support PECRB research protocols. While this is a notice of intent to sole source, small businesses are invited to submit capability statements demonstrating their ability to meet the requirement. Responses are due by April 15, 2026.
Scope of Requirement
The required instrument must meet specific technical specifications, including:
- Multiplexing capability of up to 10 assays/well.
- Detection limits between 0.5 – 1.0pg/mL and a dynamic range greater than 10^5.
- Operating temperatures of 20°C – 26°C.
- Fast plate read time of 2 minutes 45 seconds, allowing for 22 plates/hour.
- Flexibility for processing both single and multiplex assays.
- Compatibility with SECTOR™ and QuickPlex products.
- Compact size, no fluidics, and no daily or monthly user maintenance.
- Includes a touchscreen laptop computer and a limited one-year warranty.
Justification for Sole Source
Meso Scale Diagnostics LLC is identified as the only known responsible source. The QuickPlex 120 is deemed essential for the ETCHED longitudinal observational study due to its unique combination of high sensitivity, multiplexing capability, and low sample volume requirements. Alternative technologies are considered insufficient due to limitations in sample volume, lack of multiplexing, or the necessity for off-site processing, which would compromise study feasibility and data quality.
Submission & Evaluation
This is not a request for competitive quotes. However, small businesses (including 8(a), service-disabled veteran-owned, HUBZone, small disadvantaged, veteran-owned, and women-owned) are encouraged to submit a written capability statement. These statements should demonstrate their ability to perform the requirement. The government will review these responses to determine if the award can be competed.
Contract & Timeline
- Type: Presolicitation (Notice of Intent to Sole Source for a Firm-Fixed-Price purchase order)
- Product Service Code: 6640 - Laboratory Equipment And Supplies
- Set-Aside: Small businesses are invited to submit capability statements for market research purposes.
- Response Due: April 15, 2026, by 7:00 a.m. EST
- Published: April 7, 2026
- Anticipated Award: Approximately five days after the response date.
Contact
For submissions or inquiries, contact David Shen at david.shen@nih.gov.